Method of Detecting an Increased Susceptibility to Breast Cancer
OwnerFritz Parlinventor
Life of this patent
Estimating the term…
Abstract
The present invention provides methods for identifying a subject having an increased risk of developing an estrogen-related cancer, comprising determining which alleles of the genes encoding CYP1B1, CYP1A1, COMT, and GSTM1 are present in the genome of the subject so as to determine an estrogen metabolizing enzyme genotype for the subject, and correlating the estrogen metabolizing enzyme genotype of the subject to an increased risk of developing an estrogen-related cancer, for example, breast cancer. Also provided by the invention are diagnostic kits to determine the presence in a subject of the alleles of the genes encoding CYP1B1, CYP1A1, COMT, and GSTM1.
Claims21
1-6. (canceled)
A method for identifying a subject having an increased risk of developing breast cancer comprising determining the presence in the subject of an allele of each of the genes for CYP1B1, CYP1A1 and COMT that is correlated with an increased risk of developing breast cancer.
(canceled)
(canceled)
13-18. (canceled)
A method of identifying an increased risk of developing breast cancer in a subject comprising:
- (a) determining nucleic acid sequences from CYP1A1, CYP1B1 and COMT genes from a subject;
- and
- (b) correlating the presence of the nucleic acid sequences of step (a) with the presence of breast cancer in the subject, whereby the nucleic acid sequences identify alleles correlated with an increased risk of developing breast cancer.
(canceled)
A diagnostic test kit for determining the presence in a subject of alleles of CYP1B1, CYP1A1 and COMT that are correlated with an increased risk of developing breast cancer comprising a nucleic acid sequences from each of CYP1B1, CYP1A1 and COMT.
(canceled)
(canceled)
(canceled)
(canceled)
31-34. (canceled)
Dependencies are inferred from the claim text.